These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 26823029)

  • 1. Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.
    Nogami A; Yamazaki M; Saito Y; Hatsuta H; Sakiyama Y; Takao M; Kimura K; Murayama S
    J Nippon Med Sch; 2015; 82(6):266-73. PubMed ID: 26823029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series.
    Yoshida K; Hata Y; Kinoshita K; Takashima S; Tanaka K; Nishida N
    Acta Neuropathol; 2017 May; 133(5):809-823. PubMed ID: 28064358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
    Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
    Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy.
    Roemer SF; Grinberg LT; Crary JF; Seeley WW; McKee AC; Kovacs GG; Beach TG; Duyckaerts C; Ferrer IA; Gelpi E; Lee EB; Revesz T; White CL; Yoshida M; Pereira FL; Whitney K; Ghayal NB; Dickson DW
    Acta Neuropathol; 2022 Oct; 144(4):603-614. PubMed ID: 35947184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
    Hassan A; Parisi JE; Josephs KA
    Neurocase; 2012; 18(6):478-88. PubMed ID: 22181323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive supranuclear palsy combined with Alzheimer's disease: a clinicopathological study of two autopsy cases.
    Sakamoto R; Tsuchiya K; Yoshida R; Itoh Y; Furuta N; Kosuga A; Sugai Y; Mimura M
    Neuropathology; 2009 Jun; 29(3):219-29. PubMed ID: 18992014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
    Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
    Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chameleons and mimics: Progressive supranuclear palsy and corticobasal degeneration.
    Mimuro M; Yoshida M
    Neuropathology; 2020 Feb; 40(1):57-67. PubMed ID: 31515852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration.
    Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL
    Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death.
    Zhang L; Toyoshima Y; Takeshima A; Shimizu H; Tomita I; Onodera O; Takahashi H; Kakita A
    Neuropathology; 2021 Jun; 41(3):174-182. PubMed ID: 33205528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
    Yoshida M
    Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging biomarkers in tauopathies.
    Dani M; Edison P; Brooks DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S26-8. PubMed ID: 26299160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.